Seres Therapeutics, Inc.

DB:1S9 Stock Report

Market Cap: €124.3m

Seres Therapeutics, Inc. Company Information

Seres Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Seres Therapeutics, Inc.
  • Ticker: 1S9
  • Exchange: DB
  • Founded: 2010
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$138.879m
  • Listing Market Cap: US$124.255m
  • Shares Outstanding: 151.73m
  • Website: https://www.serestherapeutics.com

Number of Employees

Location

  • Seres Therapeutics, Inc.
  • 101 Cambridgepark Drive
  • Cambridge
  • Massachusetts
  • 02140
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MCRBNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDJun 2015
1S9DB (Deutsche Boerse AG)YesCommon SharesDEEURJun 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/09/26 13:58
End of Day Share Price 2024/09/26 00:00
Earnings2024/06/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.